Adjuvant Chemotherapy for Prevention of Recurrence of Invasive Hepatocellular Carcinoma After Orthotopic Liver Transplantation

Transplantation Proceedings

Volumn 38, Issue 8, 2006, Pages 2495-2498

  Bernal, E ^a   Montero, J L ^a   Delgado, M ^a   Fraga, E ^a   Costan G ^a   Barrera, P ^a   Lopez Vallejos P ^a   Solorzano G ^a   Rufian S ^a   Briceno J ^a   Padillo, J ^a   Lopez Cillero P ^a   Marchal, T ^a   Muntane J ^a   de la Mata, M ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER PATIENT; CANCER PREVENTION; CANCER RECURRENCE; CANCER SURVIVAL; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; DRUG TOLERABILITY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; KIDNEY FAILURE; LEUKOPENIA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; NAUSEA; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; STEATOSIS; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; VOMITING;

ADULT; CARCINOMA, HEPATOCELLULAR; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LIVER NEOPLASMS; MIDDLE AGED; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 33750605447     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.08.053     Document Type: Article

References (20)

1. Llovet J.M., and Beaugrand M. Hepatocellular carcinoma: present status and future prospects. J Hepatol 38 (2003) S136
2. Bruix J., Sherman M., Llovet J.M., et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona 2000 EASL Conference. J Hepatol 35 (2001) 421
3. Bruix J., and Llovet J.M. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 35 (2002) 519
4. Bruix J., Castells J., Bosch J., et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 111 (1996) 1018
5. Llovet J.M., Fuster J., and Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 39 (1999) 1434
6. Llovet J.M., Bruix J., and Gores G.J. Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy. Hepatology 31 (2000) 1019
7. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (1996) 693
8. Figueras J., Jaurrieta E., Valls C., et al. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma. Hepatology 25 (1997) 1485
9. Bismuth H., Majno P.E., and Adam R. Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 19 (1999) 311
10. Stone M.J., Klintmalm G.B., Polter D., et al. Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients. Gastroenterology 104 (1992) 196
11. Marsh J.W., Dvorchik, Subotin M., et al. The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology 26 (1997) 444
12. Roayaie S., Frischer J.S., Emre S.H., et al. Long term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg 235 (2002) 533
13. Schwartz J.D., Schwartz M., Mandelli J., et al. Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. Lancet Oncol 3 (2002) 593
14. Yokohama I., Carr B., Saitsu H., Iwatsuki S., et al. Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer 68 (1991) 2095
15. Lohmann R., Bechstein W.O., Langrehr J.M., et al. Analysis of risk factors for recurrence of hepatocellular carcinoma after orthotopic liver transplantation. Transplant Proc 27 (1995) 1245
16. Yao F.Y., Ferrell L., Bass N.M., et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33 (2001) 1394
17. Marsh J.W., and Dvorchik I. Liver organ allocation for hepatocellular carcinoma: Are we sure?. Liver Transplant 9 (2003) 693
18. Durand F., and Belghiti J. Liver transplantation for hepatocellular carcinoma: Should we push the limits?. Liver Transpl 9 (2003) 697
19. Libbretch L., Brelen D., Verslype C., et al. Focal lesions in cirrhotic explant livers: pathology evaluation and accuracy of pretransplantation imaging techniques. Liver Transpl 8 (2002) 749
20. Rode A., Bancel B., Douek P., et al. Small nodule detection in cirrhotic livers: evaluation with US, spiral CT and MRI, and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr 25 (2001) 327